Fangrong Yan

Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Acute Lymphoblastic Leukemia: First-in-Human, Phase I Trial

Jing Pan, Yue Tan, Guoling Wang et al. · Journal of Clinical Oncology · 2021 · 280 citations

Immune Signature-Based Subtypes of Cervical Squamous Cell Carcinoma Tightly Associated with Human Papillomavirus Type 16 Expression, Molecular Features, and Clinical Outcome

Xiaofan Lu, Liyun Jiang, Liya Zhang et al. · Neoplasia · 2019 · 243 citations · Full text

<i>MOVICS</i> : an R package for multi-omics integration and visualization in cancer subtyping

Xiaofan Lu, Jialin Meng, Yujie Zhou et al. · Bioinformatics · 2020 · 202 citations · Full text

Keyboard: A Novel Bayesian Toxicity Probability Interval Design for Phase I Clinical Trials

Fangrong Yan, Sumithra J. Mandrekar, Ying Yuan · Clinical Cancer Research · 2017 · 171 citations · Full text

BOIN12: Bayesian Optimal Interval Phase I/II Trial Design for Utility-Based Dose Finding in Immunotherapy and Targeted Therapies

Ruitao Lin, Yanhong Zhou, Fangrong Yan et al. · JCO Precision Oncology · 2020 · 134 citations · Full text